MX2010003711A - Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico. - Google Patents

Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico.

Info

Publication number
MX2010003711A
MX2010003711A MX2010003711A MX2010003711A MX2010003711A MX 2010003711 A MX2010003711 A MX 2010003711A MX 2010003711 A MX2010003711 A MX 2010003711A MX 2010003711 A MX2010003711 A MX 2010003711A MX 2010003711 A MX2010003711 A MX 2010003711A
Authority
MX
Mexico
Prior art keywords
sup
traumatic stress
stress disorders
treating post
tetrahydroquinoline derivatives
Prior art date
Application number
MX2010003711A
Other languages
English (en)
Spanish (es)
Inventor
Fran Ois Jenck
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40467356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010003711(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MX2010003711A publication Critical patent/MX2010003711A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2010003711A 2007-10-10 2008-10-09 Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico. MX2010003711A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2007054130 2007-10-10
PCT/IB2008/054138 WO2009047723A2 (en) 2007-10-10 2008-10-09 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders

Publications (1)

Publication Number Publication Date
MX2010003711A true MX2010003711A (es) 2010-04-30

Family

ID=40467356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003711A MX2010003711A (es) 2007-10-10 2008-10-09 Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico.

Country Status (27)

Country Link
US (1) US9532985B2 (cg-RX-API-DMAC7.html)
EP (1) EP2207550B1 (cg-RX-API-DMAC7.html)
JP (1) JP5883222B2 (cg-RX-API-DMAC7.html)
KR (1) KR101733247B1 (cg-RX-API-DMAC7.html)
CN (1) CN101820878B (cg-RX-API-DMAC7.html)
AR (1) AR068768A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309194B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818617A2 (cg-RX-API-DMAC7.html)
CA (1) CA2699504C (cg-RX-API-DMAC7.html)
CY (1) CY1114799T1 (cg-RX-API-DMAC7.html)
DK (1) DK2207550T3 (cg-RX-API-DMAC7.html)
EA (1) EA017443B1 (cg-RX-API-DMAC7.html)
ES (1) ES2444418T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140214T1 (cg-RX-API-DMAC7.html)
IL (1) IL204838A (cg-RX-API-DMAC7.html)
MA (1) MA31800B1 (cg-RX-API-DMAC7.html)
MX (1) MX2010003711A (cg-RX-API-DMAC7.html)
MY (1) MY153044A (cg-RX-API-DMAC7.html)
NZ (1) NZ585086A (cg-RX-API-DMAC7.html)
PE (1) PE20091010A1 (cg-RX-API-DMAC7.html)
PL (1) PL2207550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2207550E (cg-RX-API-DMAC7.html)
SI (1) SI2207550T1 (cg-RX-API-DMAC7.html)
TW (1) TWI428129B (cg-RX-API-DMAC7.html)
UA (1) UA99150C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009047723A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003251B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007337659A1 (en) 2006-12-22 2008-07-03 Actelion Pharmaceuticals Ltd. 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
EP2307417A2 (en) 2008-06-25 2011-04-13 Actelion Pharmaceuticals Ltd. 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist
JP5744203B2 (ja) 2010-08-24 2015-07-08 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ オレキシン受容体拮抗薬としてのプロリンスルフォンアミド誘導体
CN103153963B (zh) 2010-09-22 2014-12-24 卫材R&D管理有限公司 环丙烷化合物
CN103201261A (zh) 2010-11-10 2013-07-10 埃科特莱茵药品有限公司 用作为食欲素受体拮抗剂的内酰胺衍生物
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
US9303023B2 (en) 2011-02-18 2016-04-05 Actelion Pharmaceuticals Ltd. Pyrazole and imidazole derivatives useful as orexin antagonists
WO2012114252A1 (en) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Novel indole and pyrrolopyridine amides
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
MX343837B (es) 2011-11-08 2016-11-24 Actelion Pharmaceuticals Ltd Derivados de 2 - (1,2,3 -triazol - 2 - il) benzamida y 3 - (1,2,3 - triazol - 2 - il) picolinamida.
ES2617863T3 (es) 2012-06-04 2017-06-20 Actelion Pharmaceuticals Ltd. Derivados de bencimidazol-prolina
SG11201502493XA (en) 2012-10-10 2015-04-29 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
EA030137B1 (ru) 2013-12-03 2018-06-29 Идорсиа Фармасьютиклз Лтд Кристаллическая форма (s)-(2-(6-хлор-7-метил-1н-бензо[d]имидазол-2-ил)-2-метилпирролидин-1-ил)(5-метокси-2-(2h-1,2,3-триазол-2-ил)фенил)метанона и ее применение в качестве антагонистов орексинового рецептора
ES2696708T3 (es) 2013-12-04 2019-01-17 Idorsia Pharmaceuticals Ltd Uso de derivados de bencimidazol-prolina
RU2703297C2 (ru) 2014-10-23 2019-10-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Композиции и способы для лечения бессонницы
CN115710250A (zh) * 2017-08-01 2023-02-24 博健制药有限责任公司 一种食欲素受体拮抗剂的晶型及其制备方法和用途
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd 7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393703C (zh) * 2000-03-14 2008-06-11 埃科特莱茵药品有限公司 1,2,3,4-四氢异喹啉的衍生物
JP4637089B2 (ja) * 2003-03-26 2011-02-23 アクテリオン ファーマシューティカルズ リミテッド アセトアミド誘導体
HRP20150371T1 (hr) * 2004-03-01 2015-05-08 Actelion Pharmaceuticals Ltd. Supstituirani derivati 1,2,3,4-tetrahidroizokinolina
US7501395B2 (en) * 2005-04-25 2009-03-10 Eisai R & D Management Co., Ltd. Method of screening for antianxiety drugs
JP4582722B2 (ja) 2006-03-15 2010-11-17 アクテリオン ファーマシューティカルズ リミテッド 記憶機能を向上させるテトラヒドロイソキノリン誘導体
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist

Also Published As

Publication number Publication date
TW200932231A (en) 2009-08-01
TWI428129B (zh) 2014-03-01
EA201000557A1 (ru) 2010-10-29
JP2011500550A (ja) 2011-01-06
ZA201003251B (en) 2011-07-27
US9532985B2 (en) 2017-01-03
ES2444418T3 (es) 2014-02-25
PL2207550T3 (pl) 2014-05-30
WO2009047723A2 (en) 2009-04-16
CN101820878B (zh) 2012-02-01
KR101733247B1 (ko) 2017-05-08
JP5883222B2 (ja) 2016-03-09
KR20100065203A (ko) 2010-06-15
HK1145440A1 (en) 2011-04-21
PT2207550E (pt) 2014-02-07
MA31800B1 (fr) 2010-10-01
DK2207550T3 (da) 2014-01-27
AU2008309194B2 (en) 2013-10-03
CA2699504A1 (en) 2009-04-16
BRPI0818617A2 (pt) 2015-04-07
HRP20140214T1 (hr) 2014-04-11
WO2009047723A3 (en) 2009-05-28
IL204838A (en) 2014-09-30
UA99150C2 (ru) 2012-07-25
EP2207550B1 (en) 2013-12-11
NZ585086A (en) 2012-03-30
MY153044A (en) 2014-12-31
EP2207550A2 (en) 2010-07-21
SI2207550T1 (sl) 2014-03-31
CN101820878A (zh) 2010-09-01
IL204838A0 (en) 2010-11-30
US20100234420A1 (en) 2010-09-16
AR068768A1 (es) 2009-12-02
CY1114799T1 (el) 2016-12-14
PE20091010A1 (es) 2009-08-08
EA017443B1 (ru) 2012-12-28
AU2008309194A1 (en) 2009-04-16
CA2699504C (en) 2015-11-24

Similar Documents

Publication Publication Date Title
MX2010003711A (es) Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico.
MX2007004699A (es) Derivados de indol y bencimidazol.
GEP20125538B (en) 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases
TW200833675A (en) Nicotinamide derivatives
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
MX2014015158A (es) Derivados de piridinona y piridazinona.
MX2010006241A (es) Derivados de aminotriazol como agonistas de alx.
WO2007135527A3 (en) Benzimidazolyl compounds
TW200612958A (en) Substituted imidazole derivatives
MX2012004848A (es) Compuestos heterociclicos triciclicos.
MX2010013682A (es) Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
PT2150530E (pt) Derivados de sulfonamida substituídos
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
MX2013000474A (es) Derivados de arilamida novedosos que tienen propiedades antiandrogenicas.
TN2009000287A1 (en) Cyclized derivatives as eg-5inhibitors
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
GEP20135806B (en) Lactams as beta secretase inhibitors
PH12012501863A1 (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
PT1753723E (pt) Derivados de quinolina substituída como inibidores de quinesina mitótica
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
TW200626158A (en) Naphthaline derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
WO2009145591A3 (en) Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof

Legal Events

Date Code Title Description
FG Grant or registration